Manufacturing and Production

Showing 15 posts of 5881 posts found.

Bayer takes another shot at Monsanto acquisition

September 6, 2016 Manufacturing and Production, Sales and Marketing Bayer, acqusition, monsanto

Bayer has made another move to acquire US-based Monsanto, raising the price it is prepared to pay in an effort …
iqwigsmall

Eisai “cannot understand” German agency’s recommendation to reject Halaven

September 6, 2016 Manufacturing and Production, Research and Development Eisai, Germany, Halaven, IQWIG, german

Eisai has issued a statement to declare their “bewilderment” following a decision from the German Institute for Quality and Efficiency …
shutterstock_254160583

Taiho invests in Arcus Biosciences as part of $70 million deal

September 6, 2016 Manufacturing and Production, Sales and Marketing Arcus, investment, taiho

Taiho Ventures has invested in California-based Arcus Biosciences alongside GV, Invus, DROIA Oncology Ventures and Stanford University as part of …
shutterstock_123182704

Horizon and Fulcrum Therapeutics form CRISPR collaboration

September 6, 2016 Manufacturing and Production, Research and Development Horizon Discovery, crispr, fulcrum, fulcrum therapeutics, gene editing, horizon, rare diseases

Horizon Discovery has announced that it has entered into a partnership with Fulcrum Therapeutics to utilise Horizon’s CRISPR-based screening platform …
shutterstock_291014192

Non-invasive ventilation touted for COPD treatment at respiratory meeting

September 6, 2016 Manufacturing and Production, Research and Development COPD, resmed

ResMed has presented results at the European Respiratory Society international congress, touting home non-invasive ventilation (NIV) as part of a …
rd_hands

Takeda secures $312 million zika vaccine development contract

September 5, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Takeda, US government, Zika, world health organization

Takeda has announced that it has been granted a $312 million contract from the US government to develop an inactivated, …
gsk_boronia_australia

GSK announce positive results for chronic obstructive pulmonary disease treatment

September 5, 2016 Manufacturing and Production, Research and Development, Sales and Marketing GlaxoSmithKline, Innoviva, Revlar Ellipta, chronic obstructive pulmonary disease

GlaxoSmithKline and its partner Innoviva have announced that its Relvar Ellipta achieved positive results in its COPD Salford lung study …
top_ten

Top ten stories in the pharmaceutical industry this week

September 2, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharmafile.com, top ten

As Mylan is left reeling from the backlash on its EpiPen price increase in the US, many lost their jobs …

Sepha is fast packing with a new EZ Blister upgrade.

September 1, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Packaging Equipment Specialist, Sepha, has released a functional upgrade for one of its original products, EZ Blister, the lab scale …
cloud

Cloud on the horizon: Cloud computing and the clinical trial

September 1, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cloud Computing, ICON, clinical trials, ibm

 Originally published in the September edition of Pharmafocus, Matt Fellows investigates how cloud computing may just be the answer the …

Eli Lilly elects Jamere Jackson to board of directors

September 1, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, appointment

Eli Lilly has elected Jamere Jackson to its board of directors, effective 1 October, where he will serve on the …
novartis_iobmr

Up to 120 jobs set to go as Novartis closes down Cell and Gene Therapies unit

September 1, 2016 Manufacturing and Production, Research and Development CAR-T, Novartis, cart, cell and gene therapies

News has emerged that Novartis plans to close down its Cell and Gene Therapies unit, with up to 120 workers …

Recipharm establishes long term supply agreement with Tillotts Pharma AG

August 31, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Recipharm, the contract development and manufacturing organisation (CDMO), announces that it has entered into a long term supply agreement with …
teva_copy

Teva to lay off 236 in Pomona, New York

August 30, 2016 Manufacturing and Production, Research and Development Teva, closure

Teva is currently in the process of winding down operations at its manufacturing plant in Pomona, New York as it …
The Gateway to Local Adoption Series

Latest content


Five Facts about COPD

October 11, 2026